Page number 2

2 Editorial BUSINESS GROWTH €€ LOWER COSTS OPTIMISED PROCESSES SIMPLICITY Dear reader, We know that you are confronted with a lot of challenges in today’s European healthcare markets. And we know that just showing you where we see room for improvement through our BI services only takes you half the way. That is why we offer solutions that analyse the markets and execute our value-adding services under the PHOENIX All-in-One brand across 27 countries in Europe to solve the challenges you face. As the leading fully integrated European Healthcare Provider with Wholesale, Pre-wholesale, 2,500 own and more than 13,400 cooperation pharmacies in Europe we provide experienced experts in all our markets that help you to grow. Talk to us and we will prove to you that we can make a difference you need. We look forward to a close and successful cooperation with you! Kind regards Stefan Jung Commercial Head of Corporate Pharma Services & Sourcing PHOENIX group EUROPE 3 PHOENIX Pharmaceutical Science Awards 2018 4 Order-to-cash-cycle at Health Logistics 5 FMD workshop at International Symposium in Serbia 14 COUNTRIES 6 Netherlands: Specialised care at the patient’s home 7 Austria: Pharmacy Member Days, “Tag des Wissens” & Pharma Marketing Club Austria 8Switzerland: Healthcare Logistics partnership between Accord Healthcare and Amedis 9 Italy: Valore Salute Convention 10 Hungary: New Partnership with Zentiva 11 UK: Longtime partnership with Accord Healthcare ALL-IN-ONE NEWSFLASH 12Serbian Congress of Pharmacy // Superbrands Awards for BENU Slovakia IMPRINT The All-in-One Magazine is published by PHOENIX Pharmahandel GmbH & Co KG, Corporate Pharma Services & Sourcing, Pfingstweidstraße 10-12, 68199 Mannheim, Germany. All rights reserved, no part of this publication may be reproduced without prior permission by the publisher. Editorial Team: Olaf Christiansen (Chief Editor, +49 621 85058444, o.christiansen@phoenixgroup.eu), Reto Brändli, Carolin Dörner, Walter Fortunat, Julia Haßfeld, Clemens Homburg, Arthie Krishnasing, David Lea, Danijela Simovic, Thomas Sommereder. Title Page: PHOENIX Pharmaceutical Science Award Ceremony with industry partners in Frankfurt on 25th October 2018. Photo: Marc Fippel. Printed by: Konica Minolta Marketing Service, Köln

Page number 3

PHOENIX All-in-One | Science Awards 3 PHOENIX SUPPORTS SCIENTIFIC RESEARCH For the 22nd time, PHOENIX group has awarded the best scientific research projects with the PHOENIX Pharmaceutical Science Awards. Industry representatives from Accord, CSL Behring, Mylan and Teva joined the award ceremony in Frankfurt, Germany. Can depression be treated with Magic Mushrooms? Can a bacterium produce wound dressings? These are only two of the questions that the winners of this year’s PHOENIX Pharmacy Science Award are dealing with. On 25th October 2018, the prize, endowed with 40,000 Euros, was awarded in Frankfurt’s Palmengarten. The prize is awarded annually for innovative and outstanding research projects in the pharmaceutical sector. Participants from Germany, Switzerland and Austria submitted their contributions in four categories. An independent jury led by Professor Jörg Kreu- ter, Goethe University Frankfurt am Main, evaluated the papers from the branches pharmacology and clinical pharmacy, pharmaceutical biology, pharmaceutical chemistry and pharmaceutical technology. A gala event framed the festive award ceremony. The event also marked the start of the 25th anniversary of the PHOENIX group. In his opening speech, Oliver Windholz, CEO PHOENIX group (picture on top), referred to the almost equally long-standing acknowledgement of pharmaceutical excellence through the PHOENIX Pharmacy Science Award: “With more than 80 award-winning research projects from Germany, Austria and Switzerland, the PHOENIX Pharmaceutical Science Award is our contribution to ensuring that top pharmaceutical research has a home in the DACH region. Top-class research that can be groundbreaking for the healthcare worldwide”. PHOENIX Pharmaceutics Science Award 2018 - M olecular biological analyses of „Magic Mushrooms“ - Bacterial nanocellulose for the production of wound dressings - N ew therapeutic approaches for the treatment of non-alcoholic fatty liver hepatitis - The role of receptor Plexin-B2 and it’s ligand Semaphorin-4C in inflammatory pain

    ...